- Home
- BMRA vs TCRT Comparison
BMRA vs TCRT Comparison
Compare BMRA & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- TCRT
- Stock Information
- Founded
- BMRA 1971
- TCRT 1998
- Country
- BMRA United States
- TCRT United States
- Employees
- BMRA N/A
- TCRT N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- TCRT Health Care
- Exchange
- BMRA Nasdaq
- TCRT Nasdaq
- Market Cap
- BMRA 8.2M
- TCRT 7.0M
- IPO Year
- BMRA N/A
- TCRT N/A
- Fundamental
- Price
- BMRA $2.45
- TCRT $2.84
- Analyst Decision
- BMRA
- TCRT
- Analyst Count
- BMRA 0
- TCRT 0
- Target Price
- BMRA N/A
- TCRT N/A
- AVG Volume (30 Days)
- BMRA 30.0K
- TCRT 40.3K
- Earning Date
- BMRA 10-14-2025
- TCRT 11-14-2025
- Dividend Yield
- BMRA N/A
- TCRT N/A
- EPS Growth
- BMRA N/A
- TCRT N/A
- EPS
- BMRA N/A
- TCRT N/A
- Revenue
- BMRA $4,884,000.00
- TCRT $6,000.00
- Revenue This Year
- BMRA N/A
- TCRT $5,680,500.00
- Revenue Next Year
- BMRA N/A
- TCRT N/A
- P/E Ratio
- BMRA N/A
- TCRT N/A
- Revenue Growth
- BMRA N/A
- TCRT N/A
- 52 Week Low
- BMRA $2.08
- TCRT $1.31
- 52 Week High
- BMRA $10.16
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- BMRA 33.88
- TCRT 57.03
- Support Level
- BMRA $2.36
- TCRT $2.69
- Resistance Level
- BMRA $2.56
- TCRT $3.15
- Average True Range (ATR)
- BMRA 0.12
- TCRT 0.22
- MACD
- BMRA -0.02
- TCRT 0.03
- Stochastic Oscillator
- BMRA 13.64
- TCRT 81.93
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.